Table 4 Hematopoietic reconstitution
Parameters | Overall cohort | Outpatient treatment | Hospital admission | P-value |
|---|---|---|---|---|
Days to L <1.0 × 109/L | 4 (2–5) | 4 (3–5) | 4 (2–5) | 0.83 |
Days to L ≥1.0 × 109/L | 14 (11–20) | 15 (13–20) | 13 (11–16) | 0.11 |
Days in aplasia | 10 (7–15) | 11 (8–15) | 9 (7–11) | 0.11 |
Days to N ≥0.5 × 109/L | 14 (12–20) | 14 (13–20) | 14 (12–16) | 0.23 |
Platelets ≥20 × 109/L | ||||
Platelet transfusion, n (%) | 15 (71) | 9 (64) | 6 (86) | 0.61 |
Analysed ABSCTs, n (%) | 6 (29) | 5 (36) | 1 (14) | / |
Days to platelets ≥20 × 109/L | 10 (9–16) | 10 (9–11) | 16 | / |
Platelets ≥50 × 109/L | ||||
Days to platelets ≥50 × 109/L | 14 (11–25) | 14 (11–22) | 14 (11–25) | 0.97 |